The 2020 SARS-CoV-2 epidemic in England: key epidemiological drivers and impact of interventions
Knock, E
Whittles, L
Lees, J
Perez-Guzman, P
Verity, R
FitzJohn, R
Gaythorpe, K
Imai, N
Hinsley, W
Okell, L
Rosello, A
Kantas, N
Walters, C
Bhatia, S
Watson, O
Whittaker, C
Cattarino, L
Boonyasiri, A
Djaafara, B
Fraser, K
Fu, H
Wang, H
Xi, X
Donnelly, C
Jauneikaite, E
Laydon, D
White, P
Ghani, A
Ferguson, N
Cori, A
Baguelin, M
REACT-1 round 10 report: Level prevalence of SARS-CoV-2 swab-positivity in England during third national lockdown in March 2021
Riley, S
Eales, O
Haw, D
Walters, C
Wang, H
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Ashby, D
Donnelly, C
Cooke, G
Barclay, W
Ward, H
Darzi, A
Elliott, P
REACT-1 round 9 final report: Continued but slowing decline of prevalence of SARS-CoV-2 during national lockdown in England in February 2021
Riley, S
Wang, H
Eales, O
Haw, D
Walters, C
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Ashby, D
Donnelly, C
Cooke, G
Barclay, W
Ward, H
Darzi, A
Elliott, P
REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England in February 2021 but still at high prevalence
Riley, S
Walters, C
Wang, H
Eales, O
Haw, D
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Ashby, D
Donnelly, C
Cooke, G
Barclay, W
Ward, H
Darzi, A
Elliott, P
REACT-1 round 11 report: low prevalence of SARS-CoV-2 infection in the community prior to the third step of the English roadmap out of lockdown
Riley, S
Haw, D
Walters, C
Wang, H
Eales, O
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Page, A
Trotter, A
Le Viet, T
Alikhan, N
O’Grady, J
Consortium, T
Ashby, D
Donnelly, C
Cooke, G
Barclay, W
Ward, H
Darzi, A
Elliott, P
REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant
Riley, S
Wang, H
Eales, O
Haw, D
Walters, C
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Page, A
Prosolek, S
Trotter, A
Le Viet, T
Alikhan, N
Jackson, L
Ludden, C
Consortium, T
Ashby, D
Donnelly, C
Cooke, G
Barclay, W
Ward, H
Darzi, A
Elliott, P
SARS-CoV-2 lineage dynamics in England from January to March 2021 inferred from representative community samples
Eales, O
Page, A
Tang, S
Walters, C
Wang, H
Haw, D
Trotter, A
Le Viet, T
Foster-Nyarko, E
Prosolek, S
Atchison, C
Ashby, D
Cooke, G
Barclay, W
Donnelly, C
O’Grady, J
Volz, E
Consortium, T
Darzi, A
Ward, H
Elliott, P
Riley, S
Characterising the persistence of RT-PCR positivity and incidence in a community survey of SARS-CoV-2
Eales, O
Walters, C
Wang, H
Haw, D
Ainslie, K
Atchison, C
Page, A
Prosolek, S
Trotter, A
Le Viet, T
Alikhan, N
Jackson, L
Ludden, C
Consortium, T
Ashby, D
Donnelly, C
Cooke, G
Barclay, W
Ward, H
Darzi, A
Elliott, P
Riley, S
REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021
Riley, S
Eales, O
Haw, D
Wang, H
Walters, C
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Ashby, D
Donnelly, C
Barclay, W
Cooke, G
Ward, H
Darzi, A
Elliott, P
REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021
Elliott, P
Haw, D
Wang, H
Eales, O
Walters, C
Ainslie, K
Atchison, C
Fronterre, C
Diggle, P
Page, A
Trotter, A
Prosolek, S
Consortium, T
Ashby, D
Donnelly, C
Barclay, W
Taylor, G
Cooke, G
Ward, H
Darzi, A
Riley, S